Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer

Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies

Qiutang Li, Neurophth CSO, Named Top 25 Women Leaders in Biotechnology 2021

Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards

Neurophth Expands Its Global Gene Therapy Leadership Team with the Appointment of Dr. Zhengbin Li as Head of Commercial

First in China! Neurophth announced the first patient has been dosed in G.O.L.D. clinical trial for the gene therapy treatment of LHON

Neurophth Therapeutics and Hopstem Biotechnology Announce Strategic Partnership to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for the Treatment of Ocular Diseases

Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy

NEUROPHTH CLOSES RMB 400 MILLION SERIES B FINANCING